Literature DB >> 34117384

Distinguishing swept-source optical coherence tomography findings in active toxoplasmic retinochoroiditis.

Imen Ksiaa1, Sana Khochtali2, Mossaab Mefteh2, Manel Ben Fredj3, Hajer Ben Amor2, Nesrine Abroug2, Moncef Khairallah2.   

Abstract

OBJECTIVE: To define the swept-source optical coherence tomography (SS-OCT) features which distinguish ocular toxoplasmosis (OT) from other forms of retinochoroiditis.
METHODS: This is a prospective diagnostic study enrolling 43 eyes of 43 patients with active toxoplasmic (TOXO) retinochoroiditis matched to 54 eyes (54 lesions) with non-TOXO retinochoroiditis evaluated by structural SS-OCT.
RESULTS: The finding of retinal hyper-reflective round deposits, sub-lesional choroidal thickening, and sub-lesional retinal pigment epithelium elevation were more likely to be found in TOXO lesions with a positive likelihood ratio of 45.2 (95% CI: 6.45-316.56), 23.86 (95% CI: 6.09-93.36), and 9.79 (95% CI: 4.22-22.7), respectively. The presence of each of these findings was associated with a high level for positive predictive value (PPV) (88.63-97.29), negative predictive value (NPV) (88.3-92.45), sensitivity (83.72-90.69), and specificity (90.74-98.14). Two-parameter model binary logistic regression suggested that sub-lesional retinal pigment epithelium elevation and sub-lesional choroidal thickening were significant predictors of the diagnosis of OT (Wald = 11.905, p < 0.001; Wald = 14.881, p < 0.001; respectively). By adding hyper-reflective round deposits along the posterior hyaloid or the retinal surface the model improved its performance with very good diagnostic accuracy with area under the curve (AUC) values of 0.96 (95% CI: 0.9-0.99) for two parameters model and 0.98 (95% CI: 0.93-0.99) for the three parameters model.
CONCLUSIONS: Our results show that three OCT findings including retinal hyper-reflective round deposits, sub-lesional choroidal thickening, and sub-lesional retinal pigment epithelium elevation are more likely to occur in OT patients as compared with non-OT patients.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2021        PMID: 34117384      PMCID: PMC9151801          DOI: 10.1038/s41433-021-01491-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  16 in total

1.  Choice of analytic approach for eye-specific outcomes: one eye or two?

Authors:  Anna Karakosta; Maria Vassilaki; Sotiris Plainis; Nazik Hag Elfadl; Miltiadis Tsilimbaris; Joanna Moschandreas
Journal:  Am J Ophthalmol       Date:  2011-11-10       Impact factor: 5.258

2.  Logistic regression: a brief primer.

Authors:  Jill C Stoltzfus
Journal:  Acad Emerg Med       Date:  2011-10       Impact factor: 3.451

3.  SINGLE ACQUISITION OF THE VITREOUS, RETINA AND CHOROID WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY IN ACUTE TOXOPLASMOSIS.

Authors:  Kevin C Chen; Jesse J Jung; Michael Engelbert
Journal:  Retin Cases Brief Rep       Date:  2016

4.  Necrotic retinal pigment epithelium in toxoplasmic retinochoroiditis.

Authors:  Daniel V Vasconcelos-Santos; Wesley R Campos; Fernando Oréfice
Journal:  Acta Ophthalmol       Date:  2009-10-30       Impact factor: 3.761

5.  Multimodal Imaging in Ocular Toxoplasmosis.

Authors:  Camilo Brandão-de-Resende; Manohar Babu Balasundaram; Shishir Narain; Padmamalini Mahendradas; Daniel V Vasconcelos-Santos
Journal:  Ocul Immunol Inflamm       Date:  2020-03-11       Impact factor: 3.070

6.  A simulation study of the number of events per variable in logistic regression analysis.

Authors:  P Peduzzi; J Concato; E Kemper; T R Holford; A R Feinstein
Journal:  J Clin Epidemiol       Date:  1996-12       Impact factor: 6.437

7.  Ocular Toxoplasmosis.

Authors:  Emmett T Cunningham; Rubens Belfort; Cristina Muccioli; J Fernando Arevalo; Manfred Zierhut
Journal:  Ocul Immunol Inflamm       Date:  2015-06       Impact factor: 3.070

8.  Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography.

Authors:  Dafna Goldenberg; Michaella Goldstein; Anat Loewenstein; Zohar Habot-Wilner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-09       Impact factor: 3.117

Review 9.  Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies.

Authors:  Xiaofeng Wang; Xinge Ji
Journal:  Chest       Date:  2020-07       Impact factor: 9.410

Review 10.  A Focus on the Epidemiology of Uveitis.

Authors:  Theodora Tsirouki; Anna Dastiridou; Chrysanthos Symeonidis; Ourania Tounakaki; Irini Brazitikou; Christos Kalogeropoulos; Sofia Androudi
Journal:  Ocul Immunol Inflamm       Date:  2016-07-28       Impact factor: 3.070

View more
  1 in total

1.  In vitro and in vivo anti-Toxoplasma activities of HDAC inhibitor Panobinostat on experimental acute ocular toxoplasmosis.

Authors:  Yu Zhang; Qingqing Zhang; Haiming Li; Hua Cong; Yi Qu
Journal:  Front Cell Infect Microbiol       Date:  2022-09-12       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.